Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers

The mechanisms by which SGLT‐2 inhibitors lower albuminuria are incompletely understood. We assessed in a post‐hoc analysis of a cross‐over trial the effects of the SGLT2 inhibitor dapagliflozin on glomerular markers (IgG to IgG4 and IgG to albumin), tubular markers (urinary KIM‐1, NGAL and LFABP) a...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes Obes Metab
Main Authors: Dekkers, Claire C. J., Petrykiv, Sergei, Laverman, Gozewijn D., Cherney, David Z., Gansevoort, Ron T., Heerspink, Hiddo J. L.
Format: Artigo
Language:Inglês
Published: Blackwell Publishing Ltd 2018
Subjects:
Brief Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6055757/
https://ncbi.nlm.nih.gov/pubmed/29573529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13301
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items